Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.55 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.43 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.42 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.42 |
| ▸ | LIPE | Q05469 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.37 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.37 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.37 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.36 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29377890 | 1.00 | LIPG (0.55) | LIPGAPOBEC3GENPP2PDCD1CD274 | |
| Water SCHEMBL3179940 | 0.98 | LIPG (0.53) | LIPGAPOBEC3GENPP2PDCD1CD274 | |
| SCHEMBL2562458 | 0.93 | LIPG (0.50) | LIPGAPOBEC3GENPP2PDCD1CD274 | |
| SCHEMBL15077351 | 0.83 | APOBEC3G (0.43) | LIPGAPOBEC3GENPP2PDCD1CD274 | |
| SCHEMBL29845752 | 0.81 | LIPG (0.62) | LIPGENPP2LIPEORAI1ORAI2 | |
| SCHEMBL2560981 | 0.81 | LIPG (0.62) | LIPGENPP2LIPEORAI1ORAI2 | |
| SCHEMBL29468961 | 0.80 | LIPG (0.61) | LIPGENPP2LIPEMAPT | |
| SCHEMBL410387 | 0.80 | LIPG (0.61) | LIPGENPP2LIPEMAPT | |
| SCHEMBL5840438 | 0.79 | PDCD1 (0.52) | LIPGAPOBEC3GENPP2PDCD1CD274 | |
| SCHEMBL29955362 | 0.79 | LIPG (0.41) | LIPGAPOBEC3GENPP2PDCD1CD274 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 886 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12447133-B2 | Composition and device for preventing hypoglycemia and use thereof | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2025-10-21 | — | — | US | claimed |
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| CN-116239562-B | Method for synthesizing doxepin hydrochloride by taking benzofuranone as raw material | 江苏师范大学 | 2024-12-31 | — | — | CN | claimed |
| CN-116271202-B | Rapid self-repairing injectable nano composite antibacterial hydrogel dressing and preparation method thereof | 河南科技大学 | 2024-06-25 | — | — | CN | claimed |
| CN-118164893-A | Pentamethine cyanine dye, synthesis and application | 中国科学院大连化学物理研究所 | 2024-06-11 | — | — | CN | claimed |
| CN-115403898-B | Phenolic resin suitable for RTM process and preparation method and application thereof | 西安交通大学 | 2023-12-19 | — | — | CN | claimed |
| US-20230380457-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-30 | — | — | US | claimed |
| EP-4280882-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2023-11-29 | — | — | EP | claimed |
| US-20230363426-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-16 | — | — | US | claimed |
| WO-2011043817-A1 | COFERONS AND METHODS OF MAKING AND USING THEM | CORNELL UNIVERSITY (US) | 2011-04-14 | — | — | WO | claimed |
| EP-2307398-A1 | POLYMERISABLE COMPOUNDS FOR MAKING OPTO-ELECTRONIC DEVICES | IMEC (BE) | 2011-04-13 | — | — | EP | claimed |
| US-20110059040-A1 | COMPOSITIONS AND METHODS FOR INHIBITING VIRAL AND BACTERIAL ACTIVITY | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2011-03-10 | — | — | US | claimed |
| EP-2173362-A2 | COMPOSITIONS AND METHODS FOR INHIBITING VIRAL AND BACTERIAL ACTIVITY | University Of Utah (US) | 2010-04-14 | — | — | EP | claimed |
| WO-2010000504-A1 | POLYMERISABLE COMPOUNDS FOR MAKING OPTO-ELECTRONIC DEVICES | INTERUNIVERSITAIR MICROELEKTRONICA CENTRUM (BE) | 2010-01-07 | — | — | WO | claimed |
| WO-2009003090-A2 | COMPOSITIONS AND METHODS FOR INHIBITING VIRAL AND BACTERIAL ACTIVITY | UNIVERSITY OF UTAH (US) | 2008-12-31 | — | — | WO | claimed |
| EP-0765331-B1 | OXABOROLES AND SALTS THEREOF, AND THEIR USE AS BIOCIDES | AVECIA LTD (GB) | 2000-08-09 | — | — | EP | claimed |
| US-5880188-A | PROTECTING MEDIUM SUSCEPTIBLE TO MICROBIAL ATTACK BY TREATING WITH SPECIFIED OXABOROLE COMPOUND | ZENECA LIMITED (GB) | 1999-03-09 | — | — | US | claimed |
| EP-0765331-A1 | OXABOROLES AND SALTS THEREOF, AND THEIR USE AS BIOCIDES | ZENECA LIMITED (GB) | 1997-04-02 | — | — | EP | claimed |
| WO-1995033754-A1 | OXABOROLES AND SALTS THEREOF, AND THEIR USE AS BIOCIDES | ZENECA LIMITED (GB) | 1995-12-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110059040-A1 | COMPOSITIONS AND METHODS FOR INHIBITING VIRAL AND BACTERIAL ACTIVITY | BLVRB, RNASE1, BPGM | LIPG 167/4885APOBEC3G 626/4885ENPP2 2442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.